<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>42</viewCount><searchCount>0</searchCount></scores><additional><submitter>Bolander J</submitter><funding>European Research Council</funding><funding>Herculesstichting</funding><funding>KU Leuven</funding><funding>Dutch Research Council (NWO)</funding><funding>Fonds Wetenschappelijk Onderzoek</funding><pagination>758-772</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5355567</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(3)</volume><pubmed_abstract>Clinical translation of cell-based strategies for regenerative medicine demands predictable in vivo performance where the use of sera during in vitro preparation inherently limits the efficacy and reproducibility. Here, we present a bioinspired approach by serum-free pre-conditioning of human periosteum-derived cells, followed by their assembly into microaggregates simultaneously primed with bone morphogenetic protein 2 (BMP-2). Pre-conditioning resulted in a more potent progenitor cell population, while aggregation induced osteochondrogenic differentiation, further enhanced by BMP-2 stimulation. Ectopic implantation displayed a cascade of events that closely resembled the natural endochondral process resulting in bone ossicle formation. Assessment in a critical size long-bone defect in immunodeficient mice demonstrated successful bridging of the defect within 4 weeks, with active contribution of the implanted cells. In short, the presented serum-free process represents a biomimetic strategy, resulting in a cartilage tissue intermediate that, upon implantation, robustly leads to the healing of a large long-bone defect.</pubmed_abstract><journal>Stem cell reports</journal><pubmed_title>Healing of a Large Long-Bone Defect through Serum-Free In Vitro Priming of Human Periosteum-Derived Cells.</pubmed_title><pmcid>PMC5355567</pmcid><funding_grant_id>12S6817N</funding_grant_id><funding_grant_id>12O8715N</funding_grant_id><funding_grant_id>12I6216N</funding_grant_id><funding_grant_id>PDMK/14/203</funding_grant_id><funding_grant_id>249191</funding_grant_id><funding_grant_id>AKUL 09/001</funding_grant_id><funding_grant_id>14328</funding_grant_id><funding_grant_id>12G2715N</funding_grant_id><funding_grant_id>12C8214N</funding_grant_id><pubmed_authors>Lambrechts D</pubmed_authors><pubmed_authors>Bolander J</pubmed_authors><pubmed_authors>Leijten J</pubmed_authors><pubmed_authors>Ji W</pubmed_authors><pubmed_authors>Teixeira LM</pubmed_authors><pubmed_authors>Bloemen V</pubmed_authors><pubmed_authors>Luyten FP</pubmed_authors><pubmed_authors>Chaklader M</pubmed_authors><view_count>42</view_count></additional><is_claimable>false</is_claimable><name>Healing of a Large Long-Bone Defect through Serum-Free In Vitro Priming of Human Periosteum-Derived Cells.</name><description>Clinical translation of cell-based strategies for regenerative medicine demands predictable in vivo performance where the use of sera during in vitro preparation inherently limits the efficacy and reproducibility. Here, we present a bioinspired approach by serum-free pre-conditioning of human periosteum-derived cells, followed by their assembly into microaggregates simultaneously primed with bone morphogenetic protein 2 (BMP-2). Pre-conditioning resulted in a more potent progenitor cell population, while aggregation induced osteochondrogenic differentiation, further enhanced by BMP-2 stimulation. Ectopic implantation displayed a cascade of events that closely resembled the natural endochondral process resulting in bone ossicle formation. Assessment in a critical size long-bone defect in immunodeficient mice demonstrated successful bridging of the defect within 4 weeks, with active contribution of the implanted cells. In short, the presented serum-free process represents a biomimetic strategy, resulting in a cartilage tissue intermediate that, upon implantation, robustly leads to the healing of a large long-bone defect.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Mar</publication><modification>2024-11-05T23:41:43.24Z</modification><creation>2019-03-27T02:38:54Z</creation></dates><accession>S-EPMC5355567</accession><cross_references><pubmed>28196691</pubmed><doi>10.1016/j.stemcr.2017.01.005</doi></cross_references></HashMap>